Par Drugs and Chemicals Limited (NSE:PAR)

Market Cap	1.11B
Revenue (ttm)	984.16M
Net Income (ttm)	96.87M
Shares Out	12.30M
EPS (ttm)	7.87
PE Ratio	11.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,223
Average Volume	10,136
Open	89.51
Previous Close	91.38
Day's Range	89.51 - 93.97
52-Week Range	81.01 - 206.12
Beta	-0.45
RSI	40.39
Earnings Date	Feb 12, 2026

About Par Drugs and Chemicals

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 121
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PAR

Financial Performance

In 2024, Par Drugs and Chemicals's revenue was 1.01 billion, an increase of 5.58% compared to the previous year's 956.40 million. Earnings were 133.58 million, a decrease of -7.88%.